We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Pharmaceuticals Files ANDA for Generic Lovaza
Teva Pharmaceuticals Files ANDA for Generic Lovaza
March 17, 2009
Norway’s Pronova BioPharma and its marketing partner GlaxoSmithKline (GSK) have received notice that Teva Pharmaceuticals USA has filed an ANDA to market a generic version of the heart drug Lovaza before the expiration of patent protection.